|
CA1202840A
(en)
|
1985-06-10 |
1986-04-08 |
Jonathan R. Kleinsasser |
Combination wet and dry feeder for animals
|
|
JPS63152393A
(ja)
|
1986-07-03 |
1988-06-24 |
Takeda Chem Ind Ltd |
グリコシル誘導体
|
|
US4965195A
(en)
|
1987-10-26 |
1990-10-23 |
Immunex Corp. |
Interleukin-7
|
|
US5714585A
(en)
|
1987-10-26 |
1998-02-03 |
Sterling Winthrop, Inc. |
Antibodies that are immunoreactive with interleukin-7
|
|
US5032396A
(en)
|
1989-02-17 |
1991-07-16 |
Immunex Corporation |
IL-7 to stimulate platelet production
|
|
US5231012A
(en)
|
1989-06-28 |
1993-07-27 |
Schering Corporation |
Nucleic acids encoding cytokine synthesis inhibitory factor (interleukin-10)
|
|
US6217857B1
(en)
|
1989-06-28 |
2001-04-17 |
Schering Corporation |
Cytokine synthesis inhibitory factor (IL-10) and pharmaceutical compositions thereof
|
|
US5229115A
(en)
|
1990-07-26 |
1993-07-20 |
Immunex Corporation |
Adoptive immunotherapy with interleukin-7
|
|
US5252714A
(en)
|
1990-11-28 |
1993-10-12 |
The University Of Alabama In Huntsville |
Preparation and use of polyethylene glycol propionaldehyde
|
|
CZ282523B6
(cs)
|
1991-01-16 |
1997-07-16 |
Schering Corporation |
Iterleukin - 10 pro léčení nádorů, farmaceutický prostředek jej obsahující, jeho použití a způsob výroby
|
|
EP0495639A1
(en)
|
1991-01-16 |
1992-07-22 |
Schering Corporation |
Use of interleukin-10 in adoptive immunotherapy of cancer
|
|
US5624823A
(en)
|
1991-11-22 |
1997-04-29 |
The General Hospital Corporation |
DNA encoding procine interleukin-10
|
|
FR2686899B1
(fr)
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
|
JPH08510719A
(ja)
|
1993-02-01 |
1996-11-12 |
ユニヴェルシテ リブル ドゥ ブリュッセル アンスティテュション ダンセニュマン ユニヴェルシテル |
有効量のインターロイキン−１０、その類似体および／または作動薬を含有する医薬組成物の使用
|
|
US5328989A
(en)
|
1993-03-05 |
1994-07-12 |
Schering-Plough |
Purification of human interleukin-10 from a cell culture medium
|
|
US5552303A
(en)
|
1993-03-08 |
1996-09-03 |
Immunex Corporation |
DNA encoding epithelium-derived T-cell factor
|
|
WO1994022473A1
(en)
|
1993-04-01 |
1994-10-13 |
University Of Washington |
Use of interleukin 7 to improve vaccine potency
|
|
US5665345A
(en)
|
1993-05-24 |
1997-09-09 |
The United States Of America As Represented By The Department Of Health And Human Services |
Methods of inhibiting viral replication using IL-10
|
|
WO1995003411A1
(en)
|
1993-07-26 |
1995-02-02 |
Schering Corporation |
Agonists and antagonists of human interleukin-10
|
|
GB9317618D0
(en)
|
1993-08-24 |
1993-10-06 |
Royal Free Hosp School Med |
Polymer modifications
|
|
US5919455A
(en)
|
1993-10-27 |
1999-07-06 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
|
US5643575A
(en)
|
1993-10-27 |
1997-07-01 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
|
US5951974A
(en)
|
1993-11-10 |
1999-09-14 |
Enzon, Inc. |
Interferon polymer conjugates
|
|
NZ259584A
(en)
|
1994-01-20 |
1998-01-26 |
Schering Corp |
Cancer treatment using interleukin 10 activated peripheral blood mononuclear cells optionally combined with il-10 alone or in combination with il-2 or alpha interferon (alpha-ifn), to stimulate peripheral blood mononuclear cells
|
|
US5696234A
(en)
|
1994-08-01 |
1997-12-09 |
Schering Corporation |
Muteins of mammalian cytokine interleukin-13
|
|
US5650234A
(en)
|
1994-09-09 |
1997-07-22 |
Surface Engineering Technologies, Division Of Innerdyne, Inc. |
Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces
|
|
US5824784A
(en)
|
1994-10-12 |
1998-10-20 |
Amgen Inc. |
N-terminally chemically modified protein compositions and methods
|
|
US6410008B1
(en)
|
1994-12-12 |
2002-06-25 |
Beth Israel Hospital Association |
Chimeric IL-10 proteins and uses thereof
|
|
US5932462A
(en)
|
1995-01-10 |
1999-08-03 |
Shearwater Polymers, Inc. |
Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
|
|
US5866134A
(en)
|
1995-03-24 |
1999-02-02 |
Schering Corporation |
Method for enhancing the antibody response to specific antigens with Interleukin-10
|
|
US5770190A
(en)
|
1995-07-14 |
1998-06-23 |
Schering Corporation |
Method of treatment of acute leukemia with inteleukin-10
|
|
GB2304047A
(en)
|
1995-08-09 |
1997-03-12 |
Univ Manchester |
Pharmaceutical compositions containing cytokines
|
|
US5744451A
(en)
|
1995-09-12 |
1998-04-28 |
Warner-Lambert Company |
N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity
|
|
US5908621A
(en)
|
1995-11-02 |
1999-06-01 |
Schering Corporation |
Polyethylene glycol modified interferon therapy
|
|
US5759859A
(en)
|
1996-07-15 |
1998-06-02 |
United States Of America As Represented By The Secretary Of The Army |
Sensor and method for detecting trace underground energetic materials
|
|
US5945097A
(en)
|
1996-09-06 |
1999-08-31 |
Schering Corporation |
Method for lowering cholesterol levels with interleukin-10
|
|
US5989867A
(en)
|
1996-09-23 |
1999-11-23 |
Knappe; Andrea |
DNA encoding IL-10-like homologue; related reagents
|
|
US6660258B1
(en)
|
1997-05-09 |
2003-12-09 |
Pharma Pacific Pty Ltd |
Oromucosal cytokine compositions and uses thereof
|
|
US6608183B1
(en)
|
1997-07-14 |
2003-08-19 |
Bolder Biotechnology, Inc. |
Derivatives of growth hormone and related proteins
|
|
US5985263A
(en)
|
1997-12-19 |
1999-11-16 |
Enzon, Inc. |
Substantially pure histidine-linked protein polymer conjugates
|
|
EP1053019B1
(en)
|
1998-01-07 |
2003-12-03 |
Debio Recherche Pharmaceutique S.A. |
Degradable heterobifunctional poly(ethylene glycol) acrylates and gels and conjugates derived therefrom
|
|
US6428985B1
(en)
|
1998-12-02 |
2002-08-06 |
The Regents Of The University Of Michigan |
Immunosuppressive structural definition of IL-10
|
|
US6685931B1
(en)
|
1998-12-22 |
2004-02-03 |
Schering Corporation |
Treatment of hepatitis C virus infections with interleukin-10
|
|
US7666400B2
(en)
|
2005-04-06 |
2010-02-23 |
Ibc Pharmaceuticals, Inc. |
PEGylation by the dock and lock (DNL) technique
|
|
AU5827000A
(en)
|
1999-07-16 |
2001-02-05 |
Maria Teresa Bejarano |
Viral il-10 uses
|
|
US6989377B2
(en)
|
1999-12-21 |
2006-01-24 |
Wisconsin Alumni Research Foundation |
Treating vitamin D responsive diseases
|
|
US20030186386A1
(en)
|
2000-02-11 |
2003-10-02 |
Hansen Christian Karsten |
Interleukin 10
|
|
AU2001231532A1
(en)
|
2000-02-11 |
2001-08-20 |
Maxygen Aps |
Improved interleukin 10
|
|
ATE516820T1
(de)
|
2000-09-29 |
2011-08-15 |
Schering Corp |
Pegyliertes interleukin 10
|
|
JP2002142770A
(ja)
|
2000-11-08 |
2002-05-21 |
Dnavec Research Inc |
循環系への遺伝子送達用パラミクソウイルスベクター
|
|
US6838452B2
(en)
|
2000-11-24 |
2005-01-04 |
Vascular Biogenics Ltd. |
Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
|
|
EP1234583A1
(en)
|
2001-02-23 |
2002-08-28 |
F. Hoffmann-La Roche Ag |
PEG-conjugates of HGF-NK4
|
|
WO2002085300A2
(en)
|
2001-04-23 |
2002-10-31 |
The Regents Of The University Of California |
Methods of using interleukin-7 to modulate physiological processes in mammalian pulmonary fibroblasts
|
|
GB0212648D0
(en)
|
2002-05-31 |
2002-07-10 |
Immunoclin Lab Ltd |
Treatment with cytokines
|
|
EP1391513A1
(en)
|
2002-08-08 |
2004-02-25 |
Cytheris |
IL-7 drug substance, IL-7 comprising composition, preparation and uses thereof
|
|
EP1539960B1
(en)
|
2002-09-09 |
2010-04-28 |
Hanall Pharmaceutical Co., Ltd. |
Protease-resistant modified interferon alpha polypeptides
|
|
WO2004044006A1
(en)
|
2002-11-14 |
2004-05-27 |
Maxygen, Inc. |
Conjugates of interleukin-10 and polymers
|
|
ATE404196T1
(de)
|
2002-11-29 |
2008-08-15 |
Maria Grazia Roncarolo |
Rapamycin und il-10 zur behandlung von autoimmunerkrankungen
|
|
WO2004056850A2
(en)
|
2002-12-19 |
2004-07-08 |
Vib Vzw |
Mutant proteins showing increased secretion
|
|
ES2367430T3
(es)
|
2002-12-23 |
2011-11-03 |
Wyeth Llc |
Anticuerpos contra pd-1 y sus usos.
|
|
MXPA05006945A
(es)
|
2002-12-26 |
2005-12-14 |
Mountain View Pharmaceuticals |
Conjugados polimericos de citoquinas, quimiocinas, factores de crecimiento, hormonas polipeptidicas y sus antagonistas con actividad conservada de union al receptor.
|
|
SI2949658T1
(sl)
|
2003-03-03 |
2018-10-30 |
Dyax Corp. |
Peptidi, ki specifično vežejo HGF receptor (cMet) in njihove uporabe
|
|
ES2340494T3
(es)
|
2003-04-15 |
2010-06-04 |
Glaxosmithkline Llc |
Mutantes de sustitucion de il-18 humana y sus conjugados.
|
|
US7261882B2
(en)
|
2003-06-23 |
2007-08-28 |
Reagents Of The University Of Colorado |
Methods for treating neuropathic pain by administering IL-10 polypeptides
|
|
JPWO2005033307A1
(ja)
|
2003-09-30 |
2006-12-14 |
技術研究組合 生物分子工学研究所 |
新規のリフォールディング方法およびその方法によって得られたタンパク質
|
|
AU2004293499B2
(en)
|
2003-11-28 |
2009-11-26 |
The University Of Sydney |
Latent phase viral interleukin-10-(VII-10) and uses thereof
|
|
CA2551915C
(en)
|
2003-12-30 |
2015-06-23 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Il-7 fusion proteins
|
|
US20060078942A1
(en)
|
2004-03-10 |
2006-04-13 |
Pepgen Corporation |
Method of treatment using interferon-tau
|
|
TWI417303B
(zh)
|
2004-03-11 |
2013-12-01 |
Fresenius Kabi De Gmbh |
經由還原胺化作用製得之羥烷基澱粉及蛋白質的接合物
|
|
PT1786472E
(pt)
|
2004-08-10 |
2013-03-06 |
Genzyme Corp |
Modulação anti-sentido de expressão de apolipoproteína
|
|
US20060046961A1
(en)
|
2004-09-02 |
2006-03-02 |
Mckay William F |
Controlled and directed local delivery of anti-inflammatory compositions
|
|
CN100334112C
(zh)
|
2004-10-15 |
2007-08-29 |
上海海欣生物技术有限公司 |
人白细胞介素15与Fc融合蛋白
|
|
AU2005313492B2
(en)
|
2004-12-09 |
2011-12-15 |
Merck Patent Gmbh |
IL-7 variants with reduced immunogenicity
|
|
GB0500643D0
(en)
|
2005-01-13 |
2005-02-23 |
Renovo Ltd |
Medicaments
|
|
WO2006094530A1
(en)
|
2005-03-11 |
2006-09-14 |
Siegfried Ltd. |
Di-polymer protein conjugates and processes for their preparation
|
|
UY29460A1
(es)
|
2005-04-08 |
2006-11-30 |
Noxxon Pharma Ag |
Acidos nucleicos de union a ghrelin
|
|
US20100028296A1
(en)
|
2005-05-02 |
2010-02-04 |
Chavez Raymond A |
Use of cytokine-derived peptides in treatment of pain and neurodegenerative disease
|
|
EP1896582A4
(en)
*
|
2005-05-09 |
2009-04-08 |
Ono Pharmaceutical Co |
HUMAN MONOCLONAL ANTIBODIES AGAINST PROGRAMMED CELL DEATH 1 (PD-1) AND METHOD FOR CREATING TREATMENT WITH ANTI-PD-1 ANTIBODIES ALONE OR IN COMBINATION WITH OTHER IMMUNOTHERAPEUTICS
|
|
CA2609543C
(en)
|
2005-05-31 |
2015-03-24 |
Avigen, Inc. |
Mutant il-10
|
|
EP1910513B1
(en)
|
2005-07-01 |
2016-08-10 |
John Schrader |
Methods of isolating antibody secreting cells from blood samples of immunized animals and generating monoclonal antibodies from said antibody secreting cells.
|
|
EP1746161A1
(en)
|
2005-07-20 |
2007-01-24 |
Cytheris |
Glycosylated IL-7, preparation and uses
|
|
ATE491722T1
(de)
|
2005-10-04 |
2011-01-15 |
Zymogenetics L L C |
Herstellung und reinigung von il-29
|
|
US7939056B2
(en)
|
2005-11-14 |
2011-05-10 |
The Brigham And Women's Hospital, Inc. |
Interleukin-10 compositions for the treatment of adenocarcinomas
|
|
WO2007087576A2
(en)
|
2006-01-24 |
2007-08-02 |
The Uab Research Foundation |
Compositions and methods for the identification and treatment of immune-mediated inflammatory diseases
|
|
US7662965B2
(en)
*
|
2006-01-26 |
2010-02-16 |
Cornerstone Therapeutics, Inc. |
Anabaseine derivatives, pharmaceutical compositions and method of use thereof
|
|
MX2009003362A
(es)
|
2006-09-28 |
2009-06-08 |
Schering Corp |
Uso de interleucina-10 pegilada para tratamiento de cancer.
|
|
US20100068147A1
(en)
|
2006-10-05 |
2010-03-18 |
Agency for Science , Technology and Research |
Dengue diagnosis and treatment
|
|
US8247370B2
(en)
|
2006-12-04 |
2012-08-21 |
Promedior, Inc. |
Conjoint therapy for treating fibrotic diseases
|
|
AU2008206077A1
(en)
|
2007-01-19 |
2008-07-24 |
Kai Pharmaceuticals, Inc. |
Modifications of peptide compositions to increase stability and delivery efficiency
|
|
US20090028857A1
(en)
|
2007-07-23 |
2009-01-29 |
Cell Genesys, Inc. |
Pd-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof
|
|
CA2694139C
(en)
|
2007-07-31 |
2018-06-05 |
Affibody Ab |
Albumin binding polypeptide compositions
|
|
WO2009036568A1
(en)
|
2007-09-19 |
2009-03-26 |
University Health Network |
Methods and compositions for treating tumors and viral infections
|
|
EP2959917A3
(en)
|
2007-10-19 |
2016-02-24 |
The Regents of The University of California |
Compositions and methods for ameliorating cns inflammation, psychosis, delirium, ptsd or ptss
|
|
US7960145B2
(en)
|
2007-11-08 |
2011-06-14 |
Cytimmune Sciences, Inc. |
Compositions and methods for generating antibodies
|
|
GB0724231D0
(en)
|
2007-12-12 |
2008-01-30 |
Renono Ltd |
Methods for inhibiting scarring
|
|
MX2010012579A
(es)
|
2008-05-29 |
2010-12-20 |
Squibb Bristol Myers Co |
Metodos para predecir respuesta de pacientes a modulacion de la via co-estimuladora.
|
|
WO2010022227A1
(en)
|
2008-08-20 |
2010-02-25 |
Schering Corporation |
Methods for monitoring il-10 therapy
|
|
KR20110112301A
(ko)
|
2008-11-18 |
2011-10-12 |
메리맥 파마슈티컬즈, 인크. |
인간 혈청 알부민 링커 및 그 콘쥬게이트
|
|
US8691205B2
(en)
|
2008-12-17 |
2014-04-08 |
Merck Sharp & Dohme Corporation |
Mono- and di-PEG IL-10 production; and uses
|
|
CA2769822C
(en)
*
|
2009-08-13 |
2019-02-19 |
The Johns Hopkins University |
Methods of modulating immune function
|
|
US10464987B2
(en)
|
2009-10-06 |
2019-11-05 |
Abbvie Inc. |
Human single-chain T cell receptors
|
|
EP2949671A1
(en)
|
2009-10-12 |
2015-12-02 |
Pfizer Inc |
Cancer treatment
|
|
CN102741280B
(zh)
|
2009-10-30 |
2015-12-02 |
诺维信生物制药丹麦公司 |
白蛋白变体
|
|
AU2010323036B2
(en)
|
2009-11-30 |
2015-01-29 |
Biotest Ag |
Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE)
|
|
CA3253628A1
(en)
*
|
2010-03-05 |
2025-11-29 |
The Johns Hopkins University |
Compositions and methods for targeted immunomodulatory antibodies and fusion proteins
|
|
SG186302A1
(en)
|
2010-06-16 |
2013-02-28 |
Abbott Lab |
Comparison of protein samples
|
|
CA2802344C
(en)
|
2010-06-18 |
2023-06-13 |
The Brigham And Women's Hospital, Inc. |
Bi-specific antibodies against tim-3 and pd-1 for immunotherapy in chronic immune conditions
|
|
CN110437320B
(zh)
|
2010-07-09 |
2023-10-20 |
阿菲博迪公司 |
多肽
|
|
US8759617B2
(en)
|
2010-09-21 |
2014-06-24 |
National Institute Of Agrobiological Sciences |
Method for extraction and purification of recombinant proteins from transgenic plants
|
|
BR112013007385B1
(pt)
|
2010-09-28 |
2022-07-26 |
Amylin Pharmaceuticals, Llc |
Polipeptídeo quimérico, seu uso e composição que o compreende
|
|
BR112013007442A2
(pt)
|
2010-09-28 |
2019-09-24 |
Amylin Pharmaceuticals Llc |
polipeptídeos construídos tendo duração de ação realçada
|
|
US8895537B2
(en)
|
2010-10-29 |
2014-11-25 |
Infirst Healthcare Ltd. |
Compositions and methods for treating cardiovascular diseases
|
|
BR112013024395B1
(pt)
|
2011-03-23 |
2021-10-26 |
Fred Hutchinson Cancer Research Center |
Composições adotivas de imunoterapia celular e método para fabricação da dita composição
|
|
CN102145178B
(zh)
|
2011-04-15 |
2012-09-26 |
北京凯因科技股份有限公司 |
Peg化白介素15
|
|
EP2537933A1
(en)
|
2011-06-24 |
2012-12-26 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
An IL-15 and IL-15Ralpha sushi domain based immunocytokines
|
|
US20140242081A1
(en)
*
|
2011-07-18 |
2014-08-28 |
Micromet Ag |
Dosing regimens for treatment of cea-expressing cancers
|
|
US20140256626A1
(en)
|
2011-10-18 |
2014-09-11 |
Prolynx Llc |
Peg conjugates of exenatide
|
|
WO2013074916A1
(en)
|
2011-11-18 |
2013-05-23 |
Board Of Regents, The University Of Texas System |
Car+ t cells genetically modified to eliminate expression of t- cell receptor and/or hla
|
|
MX2014009129A
(es)
|
2012-01-26 |
2014-11-21 |
Amgen Inc |
Polipeptidos de factor 15 de diferenciacion de crecimiento (gdf-15).
|
|
WO2013130913A1
(en)
|
2012-02-29 |
2013-09-06 |
Ambrx, Inc. |
Interleukin-10 polypeptide conjugates and their uses
|
|
US20150118244A1
(en)
|
2012-05-10 |
2015-04-30 |
Bristol-Myers Squibb Company |
Anti-tumor antibodies as predictive or prognostic biomarkers of efficacy and survival in ipilimumab-treated patients
|
|
DK2947111T3
(en)
|
2013-01-17 |
2018-05-07 |
Xiamen Sinopeg Biotech Co Ltd |
MONOFUNCTIONAL BRANCHED POLYETHYLENE LYCOL AND BIORELATED SUBSTANCE MODIFIED BY SAME
|
|
AU2014254019B2
(en)
|
2013-04-18 |
2018-09-27 |
Armo Biosciences, Inc. |
Methods of using interleukin-10 for treating diseases and disorders
|
|
HK1215595A1
(zh)
|
2013-04-24 |
2016-09-02 |
Armo Biosciences, Inc. |
白細胞介素-10藥物組合物和使用方法
|
|
AU2014281828B2
(en)
|
2013-06-17 |
2019-05-09 |
Armo Biosciences, Inc. |
Method for assessing protein identity and stability
|
|
HK1226308A1
(zh)
|
2013-08-30 |
2017-09-29 |
Armo Biosciences, Inc. |
使用白细胞介素-10治疗疾病和病症的方法
|
|
BR112016010166A2
(pt)
|
2013-11-11 |
2017-12-05 |
Armo Biosciences Inc |
métodos para usar interleucina-10 para tratar doenças e distúrbios
|
|
US20160375101A1
(en)
|
2014-01-15 |
2016-12-29 |
Armo Biosciences, Inc. |
Methods of Using Interleukin-10 for Treating Diseases and Disorders
|
|
EP4303229A3
(en)
|
2014-01-21 |
2024-04-17 |
Novartis AG |
Enhanced antigen presenting ability of car t cells by co-introduction of costimulatory molecules
|
|
MA39711A
(fr)
|
2014-04-03 |
2015-10-08 |
Nektar Therapeutics |
Conjugués d'une fraction d'il-15 et d'un polymère
|
|
US10293043B2
(en)
|
2014-06-02 |
2019-05-21 |
Armo Biosciences, Inc. |
Methods of lowering serum cholesterol
|
|
KR20170125839A
(ko)
|
2015-03-11 |
2017-11-15 |
넥타르 테라퓨틱스 |
Ｉｌ-7 부분 및 중합체의 접합체
|
|
CN107847583A
(zh)
|
2015-05-28 |
2018-03-27 |
阿尔莫生物科技股份有限公司 |
用于治疗癌症的聚乙二醇化白细胞介素‑10
|